Advocacy & Policy

Advocacy, Education & Lobbying
Learn about how the Society for Immunotherapy of Cancer advocating toward the advancement of cancer immunotherapy research. Activities include Joe Biden's Cancer Moonshot Initiative, 21st Century Cures Act and more.

Regulatory Issues
SITC leaders have prioritized Adverse Events Reporting, Clinical Trial Design/Endpoints and Combination Approaches in approaching regulatory issues relating to the field of cancer immunotherapy.

Standards & Quality of Care
SITC is the first and only organization dedicated to cancer immunotherapy to be accepted as a formal member of the Commission on Cancer (CoC), a program of the American College of Surgeons.

Value of Immunotherapy
Learn what programs and initiatives the society is partaking in to further the advancement and understanding on the value of immunotherapy.